centerforurologiccare.com
Nov 15, 2024, 12:02
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X:
“Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
NIAGARA trial
Event Free Survival and Overall Survival.
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Authors: Thomas Powles, James W.F. Catto, Matthew D. Galsky, Hikmat Al-Ahmadie, Joshua J. Meeks, Hiroyuki Nishiyama, Toan Quang Vu, Lorenzo Antonuzzo, Pawel Wiechno, Vagif Atduev, Ariel G. Kann, Tae-Hwan Kim, Cristina Suárez, Chao-Hsiang Chang, Florian Roghmann, Mustafa Özgüroğlu, Bernhard J. Eigl, Niara Oliveira, Tomas Buchler, Moran Gadot, Yousef Zakharia, Jon Armstrong, Ashok Gupta, Stephan Hois, Michiel S. van der Heijden.”
Ariel G. Kann
Ashok Gupta
Bernhard J. Eigl
bladder cancer
cancer
Chao-Hsiang Chang
Cristina Suárez
event-free survival
Florian Roghmann
Hikmat Al-Ahmadie
Hiroyuki Nishiyama
James W.F. Catto
Jon Armstrong
Joshua J. Meeks
Lorenzo Antonuzzo
Matthew D. Galsky
Michiel S. Van der Heijden
Moran Gadot
Mustafa Özgüroğlu
Neoadjuvant chemotherapy (NACT)
Niara Oliveira
OncoDaily
Oncology
overall survival
Pawel Wiechno
Perioperative Durvalumab
Stephan Hois
Tae-Hwan Kim
Thomas Powles
Toan Quang Vu
Tomas Buchler
Vagif Atduev
Yakup Ergün
Yousef Zakharia
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 12:02
Nov 15, 2024, 07:51
Nov 15, 2024, 07:46
Nov 15, 2024, 07:05
Nov 15, 2024, 07:03